Barbara Heckman
ORCID:0000-0002-2289-7387
发表论文 39 篇 · 总被引 670 次 · h-index 17
代表论文
- Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study (2018 · Journal of the Pediatric Infectious Diseases Society · 被引 44)
- Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women (2013 · Clinical Infectious Diseases · 被引 34)
- Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study (2024 · The Lancet HIV · 被引 30)
- Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV (2022 · AIDS and Behavior · 被引 28)
- Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study (2024 · The Lancet HIV · 被引 26)
- CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection (2017 · AIDS · 被引 23)